Back to Search Start Over

T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection

Authors :
Fritz von Weizsäcker
S. Urbani
Elisabeth Panther
Robert Thimme
Carlo Ferrari
Tobias Boettler
Hans Christian Spangenberg
Christoph Neumann-Haefelin
Hubert E. Blum
Publication Year :
2005
Publisher :
American Society for Microbiology, 2005.

Abstract

Chronic hepatitis C virus (HCV) infection is associated with impaired proliferative, cytokine, and cytotoxic effector functions of HCV-specific CD8 + T cells that probably contribute significantly to viral persistence. Here, we investigated the potential role of T cells with a CD4 + CD25 + regulatory phenotype in suppressing virus-specific CD8 + T-cell proliferation during chronic HCV infection. In vitro depletion studies and coculture experiments revealed that peptide specific proliferation as well as gamma interferon production of HCV-specific CD8 + T cells were inhibited by CD4 + CD25 + T cells. This inhibition was dose dependent, required direct cell-cell contact, and was independent of interleukin-10 and transforming growth factor beta. Interestingly, the T-cell-mediated suppression in chronically HCV-infected patients was not restricted to HCV-specific CD8 + T cells but also to influenza virus-specific CD8 + T cells. Importantly, CD4 + CD25 + T cells from persons recovered from HCV infection and from healthy blood donors exhibited significantly less suppressor activity. Thus, the inhibition of virus-specific CD8 + T-cell proliferation was enhanced in chronically HCV-infected patients. This was associated with a higher frequency of circulating CD4 + CD25 + cells observed in this patient group. Taken together, our results suggest that chronic HCV infection leads to the expansion of CD4 + CD25 + T cells that are able to suppress CD8 + T-cell responses to different viral antigens. Our results further suggest that CD4 + CD25 + T cells may contribute to viral persistence in chronically HCV-infected patients and may be a target for immunotherapy of chronic hepatitis C.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....3c3e79ebeac7b9f47ab7249c0a81a3c4